Skip to content

FREE DELIVERY (UK ORDERS OVER £50) | ☎ 0161 884 0507 | Mon-Fri 9-5pm | Email/Chat Reply with-in 1 hour - 24/7

DMSO and Inflammation: Evidence, Insights, and Caution

17 Aug, 2025 1
DMSO and Inflammation: Evidence, Insights, and Caution

DMSO and Inflammation: What the Research Really Shows

Research Roundup

Inflammation is a protective response, but when it lingers, it becomes a driver of chronic diseases ranging from arthritis to cardiovascular illness. DMSO has been studied for its potential anti-inflammatory properties since the 1960s, but the evidence is a mix of promise and unanswered questions.

  • Early laboratory findings (1960s–70s): Researchers noted DMSO’s ability to scavenge free radicals and reduce cellular oxidative damage. These mechanisms are central to controlling inflammation.

  • Animal models: Several rodent studies (including a 1985 study in Inflammation Research) showed reduced swelling and tissue injury when DMSO was applied to chemically induced inflammation.

  • Small human trials: Some early clinical trials in arthritis patients suggested reduced stiffness and pain, thought to be linked to dampened inflammatory pathways. However, results were inconsistent, and sample sizes were small.

  • Modern perspective: Newer studies have focused more on DMSO’s role as a solvent in drug delivery, but its standalone anti-inflammatory potential remains under-investigated in large human populations.

The science suggests a plausible mechanism — antioxidant action, membrane stabilization, and modulation of cytokines — but without large-scale human trials, the claims remain tentative.


Expert Perspective (Rheumatologist’s View)

A rheumatologist might frame DMSO as biologically intriguing but clinically unproven. Its ability to reduce oxidative stress is well documented in labs, but translating that into reliable treatments for chronic inflammation hasn’t been achieved.

  • Potential upside: If controlled properly, DMSO could one day serve as a delivery system for anti-inflammatory drugs, improving tissue penetration.

  • Limitations: Lack of standard dosing, unpredictable absorption, and potential side effects (skin irritation, garlic-like breath odor, headaches) keep it from clinical use.

  • Clinical caution: Without regulatory approval and high-quality human trials, most physicians do not recommend DMSO as an anti-inflammatory therapy.


The Bottom Line

DMSO shows genuine anti-inflammatory activity in controlled environments, but until robust human data emerges, it belongs in the realm of research, not routine therapy. For now, it’s best considered an experimental tool with potential, rather than a proven treatment.


Disclaimer

This article is for educational purposes only. DMSO is not an approved treatment for inflammatory conditions. Always seek professional medical advice before considering any new therapies.